SHEMESH SHAY (Chief Development Officer) purchased 0.1% of their position (1.11K shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $7.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/13/2024ACC: 0001104659-24-060261
Officer· Chief Development Officer
Since Feb 2022
+1.11K
Net shares
Net buyer
$7.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.11K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.11K
Price / share
$6.32
Trade value
$7.03K
% of position
0.1%
5/10/2024
1.49M→1.49M
Total
Net shares
+1.11K
Net value
$7.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/10/2024 | P · Purchase | +1.11K | $6.32 | $7.03K | 0.1% | 1.49M | 1.49M |
| Total | +1.11K | $7.03K | ||||||
Derivative Transactions0
No derivative transactions reported